
Dear colleagues,
Human myocarditis remains a critical clinical challenge, particularly regarding its cause, progression and treatment. Myocarditis may vary from one case to another and remarkably influence the patient outcome.
The morpho-molecular characterization of inflamed myocardium through endomyocardial biopsy is extremely helpful and mandatory for the most severe and progressive forms. The risks of the procedure are very limited (< 1%), particularly when performed by experts in centers for cardiac surgery support. In terms of cause, myocarditis can be the result of infectious agents, autoreactive mechanisms or clear-cut autoimmune disorders. New pathways of myocardial inflammation, e.g., gout and psoriasis, have been recently reported, thus extending and improving the modalities of therapeutic intervention.
The aim of the present webinar is to present new insights on human myocarditis with help from some key experts on the topic.
Date: 05 October 2023 at 2:00 p.m. CEST | 8:00 a.m. EDT | 8:00 p.m. CST Asia
Webinar ID: 876 4060 1856
Webinar Secretariat: journal.webinar@mdpi.com


On Thursday, 05 October 2023, MDPI and the Journal of Clinical Medicine organized a webinar entitled "New Insights in Human Myocarditis: From Bench to Bedside".
Myocarditis represents the inflammation of the myocardium that may manifest in various disorders including infectious, storage, ischemic, traumatic and metabolic diseases. The morpho-molecular characterization of the inflamed tissue via endomyocardial biopsy is a pre-requisite to establish a personalized therapy with the improvement of the patient's outcome, particularly for those with an unfavorable clinical course.
This webinar was hosted via Zoom and required registration to attend. The full recording can be found below. In order to learn about future webinars, be sure to sign up to our newsletter by clicking “Subscribe” at the top of the page.